메뉴 건너뛰기




Volumn 125, Issue 5, 1996, Pages 369-375

A Prognostic Model for Predicting 10-Year Survival in Patients with Primary Melanoma

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; MELANOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK; SEX DIFFERENCE; SKIN TUMOR; STATISTICAL MODEL;

EID: 0030240674     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-5-199609010-00003     Document Type: Article
Times cited : (159)

References (17)
  • 2
    • 0028208538 scopus 로고
    • Etiology, epidemiology, risk factors, and public health issues of melanoma
    • Elwood JM, Koh HK. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol. 1994;6:179-87.
    • (1994) Curr Opin Oncol. , vol.6 , pp. 179-187
    • Elwood, J.M.1    Koh, H.K.2
  • 3
    • 0025277124 scopus 로고
    • Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease
    • Masri GD, Clark WH Jr, Guerry D 4th, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol. 1990;22(6 Pt 1):1042-8.
    • (1990) J Am Acad Dermatol. , vol.22 , Issue.6 PART 1 , pp. 1042-1048
    • Masri, G.D.1    Clark Jr., W.H.2    Guerry IV, D.3    Halpern, A.4    Thompson, C.J.5    Elder, D.E.6
  • 6
    • 0014884119 scopus 로고
    • Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
    • Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902-8.
    • (1970) Ann Surg. , vol.172 , pp. 902-908
    • Breslow, A.1
  • 7
    • 0018108412 scopus 로고
    • A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark's and Breslow's staging methods
    • Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 1978;188:732-42.
    • (1978) Ann Surg. , vol.188 , pp. 732-742
    • Balch, C.M.1    Murad, T.M.2    Soong, S.J.3    Ingalls, A.L.4    Halpern, N.B.5    Maddox, W.A.6
  • 8
    • 0018509979 scopus 로고
    • A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma
    • Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery. 1979;86:343-51.
    • (1979) Surgery , vol.86 , pp. 343-351
    • Balch, C.M.1    Soong, S.J.2    Murad, T.M.3    Ingalls, A.L.4    Maddox, W.A.5
  • 9
    • 0020078461 scopus 로고
    • Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). A conceptual model for tumor growth and metastasis
    • Day CL Jr, Mihm MC Jr, Lew RA, Harris MN, Kopf AW, Fitzpatrick TB, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). A conceptual model for tumor growth and metastasis. Ann Surg. 1982;195:35-43.
    • (1982) Ann Surg. , vol.195 , pp. 35-43
    • Day Jr., C.L.1    Mihm Jr., M.C.2    Lew, R.A.3    Harris, M.N.4    Kopf, A.W.5    Fitzpatrick, T.B.6
  • 11
    • 0027237207 scopus 로고
    • Treatment of human melanoma with a hapten-modified autologous vaccine
    • Berd D, Maguire HC Jr, Mastrangelo MJ. Treatment of human melanoma with a hapten-modified autologous vaccine. Ann N Y Acad Sci. 1993;690: 147-52.
    • (1993) Ann N Y Acad Sci. , vol.690 , pp. 147-152
    • Berd, D.1    Maguire Jr., H.C.2    Mastrangelo, M.J.3
  • 12
    • 0028205790 scopus 로고
    • Improved survival in stage III melanoma patients with GM2 antibodies: A randomized trial of adjuvant vaccination with GM2 ganglioside
    • Livingston PO, Wong GY, Adluri S, Tao Y, Padavan M, Parente R, et al. Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol. 1994;12:1036-44.
    • (1994) J Clin Oncol. , vol.12 , pp. 1036-1044
    • Livingston, P.O.1    Wong, G.Y.2    Adluri, S.3    Tao, Y.4    Padavan, M.5    Parente, R.6
  • 13
    • 0030030347 scopus 로고    scopus 로고
    • Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
    • Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7-17.
    • (1996) J Clin Oncol. , vol.14 , pp. 7-17
    • Kirkwood, J.M.1    Strawderman, M.H.2    Ernstoff, M.S.3    Smith, T.J.4    Borden, E.C.5    Blum, R.H.6
  • 16
    • 0020083498 scopus 로고
    • The meaning and use of the area under a receiving operating characteristic (ROC) curve
    • Hanley JA, McNeil BJ. The meaning and use of the area under a receiving operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
    • (1982) Radiology , vol.143 , pp. 29-36
    • Hanley, J.A.1    McNeil, B.J.2
  • 17
    • 0020524559 scopus 로고
    • A method of comparing the areas under receiver operating characteristic curves derived from the same cases
    • Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148:839-43.
    • (1983) Radiology , vol.148 , pp. 839-843
    • Hanley, J.A.1    McNeil, B.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.